Nexera XR Tried and trusted all-rounder

Article

Sponsored Content

A true multi-talent, the Nexera XR ultra high performance liquid chromatograph has become an indispensable tool in laboratories of versatile industries, such as pharmaceuticals, biochemistry, chemistry, environmental and foods. Users benefit from high-speed, high-resolution analysis without compromising robustness or reliability.

 

The Nexera XR modular UHPLC system bridges the gap between the flexibility clients need and the reliability they want. The wide range of highly accurate and reliable modules provides the optimum system for analytical challenges in any field.

 

On the safe side – with a pressure resistance of 660 bar, the Nexera XR is a reliable all-round system, providing the superior performance of UHPLC with the robustness of a conventional HPLC system.

 

The flexible choice – modular design allows configuration of tailor-made systems to meet specific application requirements. Each module delivers outstanding, reliable performance from HPLC to UHPLC application.

 

The sensible option – the SPD-30AM multi-wavelength detector and RF-20Axs fluorescence detector offer unmatched performance. Equipped with unequalled optics and temperature control, these detectors achieve excellent sensitivity, baseline stability and reproducibility.

 

For more information please visit www.shimadzu.eu

Recent Videos
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Related Content